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Objective: To establish the role of Kv7 channels in EPAC dependent relaxations of the rat 
vasculature, and investigate whether this contributes to β-adrenoceptor mediated 
vasorelaxations 
Approach: Isolated rat renal and mesenteric arteries (RA and MA respectively) were used for 
isometric tension recording to study the relaxant effects of a specific EPAC activator and the 
β-adrenoceptor agonist isoproterenol in the presence of potassium channel inhibitors and 
cell signalling modulators. Isolated myocytes were used in proximity ligation assay studies to 
detect localisation of signalling intermediaries with Kv7.4 before and after cell stimulation. 
Results: Our studies showed that the EPAC activator (8-pCPT-2Me-cAMP-AM) produced 
relaxations and enhanced currents of MA and RA that were sensitive to linopirdine (Kv7 
inhibitor). Linopirdine also inhibited isoproterenol mediated relaxations in both RA and MA. In 
the MA isoproterenol relaxations were sensitive to EPAC inhibition, but not protein kinase A 
inhibition. In contrast, isoproterenol relaxations in RA were attenuated by protein kinase A 
but not by EPAC inhibition. Proximity ligation assay showed a localisation of Kv7.4 with A-
Kinase anchoring protein in both vessels in the basal state which increased only in the RA 
with isoproterenol stimulation. In the MA, but not the RA, a localisation of Kv7.4 with both 
Rap1a and Rap2 (downstream of EPAC) increased with isoproterenol stimulation. 
Conclusions: EPAC dependent vasorelaxations occur in part via activation of Kv7 channels. 
This contributes to the isoproterenol mediated relaxation in mesenteric, but not renal, 
arteries. 
 
Abbreviations: A-kinase anchoring protein (AKAP); large conductance Ca2+ activated K+ 
channel (BKCa); cyclic AMP (cAMP); exchange protein directly activated by cAMP (EPAC); 
guanine nucleotide exchange factor (GEF); ATP-sensitive K+ channel (KATP); mesenteric 
artery (MA); protein kinase A (PKA); renal artery (RA) 
 
Introduction 
The first account of Kv7 channels contributing to physiologically relevant receptor-mediated 
vasorelaxations showed that pharmacological blockade of Kv7 channels or Kv7.4 
knockdown resulted in impaired responses to the mixed β-adrenoceptor agonist 
isoproterenol in the rat renal artery1. Subsequently, studies have shown that other 
vasodilatory agents which also work through increasing intracellular cyclic AMP (cAMP) 
levels via Gs coupled receptor activation, also produce vasorelaxations which are Kv7 
dependent (adenosine2 and forskolin3 in coronary artery, CGRP4 and forskolin5 in cerebral 
artery). Now that cAMP signalling is well recognised as regulatory to vascular Kv7 channels, 
the downstream signalling events which are responsible for this regulation need to be 
established.  
Cyclic AMP activity stimulates two main intracellular signalling molecules – protein kinase A 
(PKA) and the exchange protein directly activated by cAMP (EPAC). In the vasculature PKA 
activity has been extensively researched and is involved in a myriad of regulatory processes 
which result in vasorelaxation6. One of the prime targets of PKA is the A Kinase Anchoring 
Protein (AKAP) which is involved in cardiac and neuronal Kv7 channel regulation 7, 8, 9. By 
contrast, EPAC is more recently discovered and its effects are only beginning to be 
characterised (see 10-12 for recent reviews). EPAC acts as a guanine nucleotide exchange 
factor (GEF) and activates a number of small proteins, most prominently Rap proteins, which 
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have important vascular effects13-17. EPAC stimulation has been shown to contribute to 
vasorelaxations in rat mesenteric arteries18, 19, in part via activation of calcium activated K 
channels (BKCa) 16 but the role of other vascular K channels in this process is unclear. 
Here we aim to establish the role of Kv7 channels in EPAC dependent relaxations, and 
whether this contributes to the isoproterenol mediated relaxation of vessels.  
 
Materials and Methods 
Materials and methods are available in the online data supplement 
 
Results 
EPAC activation produces Kv7 dependent vessel specific relaxation  
To examine the possible role of Kv7 channels in EPAC dependent relaxations in MA, we 
used the EPAC specific activator 8-pCPT-2Me-cAMP-AM at a concentration selective for 
EPAC (5µmol/L). This produced relaxations of both the MA and RA (n=13 and n=8, 
respectively Figure 1B and C). As it has previously been shown that BKCa channels have a 
role in this process18, we inhibited this channel with 1µmol/L paxilline which produced an 
impairment of the EPAC dependent relaxation in both MA and RA (n=5) but not complete 
blockade. To investigate the role of Kv7 channels, we used the pan-Kv7 channel blocker 
linopirdine, which inhibited 8-pCPT-2Me-cAMP-AM -mediated relaxations in MA at both 1 
and 10 μmol/L (n=6). In combination paxilline and linopirdine produced an additive inhibition 
of EPAC relaxation in the MA (n=6). In the RA linopirdine reduced relaxation to the EPAC 
activator at both 1µmol/L (n=6) and 10µmol/L (n=5), but an additive effect with 1µmol/L 
paxilline was not seen (n=4). 
Relaxations to 5µmol/L 8-pCPT-2Me-cAMP-AM were also tested in the presence of the 
Kv7.1 inhibitor HMR1556 (10µmol/L) and the EPAC inhibitor ESI-09 (300nmol/L). HMR1556 
had no effect on relaxations in either MA or RA (n=3-6). 300nmol/L ESI-09 significantly 
inhibited the relaxation in both beds (n=3-5, Supplementary Figure 1) without any effect on 
basal tone. Previous reports have concluded that EPAC relaxations are endothelium 
dependent18, 19, so we tested the effect of 5µmol/L 8-pCPT-2Me-cAMP-AM in MA 
endothelium denuded segments, which was assessed by the vasorelaxant response to 
10µmol/L carbachol. Vessels with <20% relaxation to 10µmol/L carbachol were used for 
these experiments and we saw no effect of endothelium denudation on responses to 8-
pCPT-2Me-cAMP-AM (n=6, Supplementary Figure 2).  
To test the effect of EPAC stimulation directly on Kv7 channels, we used myocytes isolated 
from renal and mesenteric arteries and recorded whole cell K+ currents which were sensitive 
to 10µmol/L linopirdine (in the presence of 1µmol/L paxilline) before and after application of 
1µmol/L 8-pCPT-2Me-cAMP-AM. In both RA and MA arterial myocytes we recorded a 
significant increase in the linopirdine sensitive current in the presence of the EPAC activator 
(Figure 1 D and E). We also utilised HEK293 cells which stably express Kv7.4 – the most 
abundant Kv7 isoform in the vasculature shown to be enhanced by cAMP20-22 and the 
isoform which has been most commonly implicated in mediating vasorelaxations1-5, 23-30. End 
point PCR showed that these cells express both the EPAC1 and EPAC2 isoforms 
(Supplementary Figure 3). Kv7.4 channels produce voltage dependent currents when 
expressed in HEK293 cells, which increased significantly after addition of 1µmol/L 8-pCPT-
2Me-cAMP-AM (1.6 ±0.3 times increase maximal current at -20mV in control, n=7, Figure 
1F). This was associated with a leftward shift of the activation curve, with a change in V1/2 
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from -7.2mV in control to -17.5mV after addition of 1µmol/L 8-CPT-2Me-cAMP (n=7, Figure 
1G). 
Signalling pathways involved in isoproterenol relaxations  
We next sought to establish if EPAC dependent signalling via Kv7 channels contributes to 
isoproterenol mediated vasorelaxations. Isoproterenol produced dose dependent relaxations 
of MA which were significantly attenuated in the presence of 10µmol/L linopirdine (Figure 
2A, n=9) or 1µmol/L paxilline and an additive inhibitory effect was seen when both agents 
were used (Figure 2B, n=5). This same pattern was seen in the RA (Figure 2C and 2D, 
n=5-7) where the role of Kv7 and other K+ channels in isoproterenol relaxations has 
previously been fully characterised1. In MA, blockade of KATP channels (10µmol/L 
glibenclamide) had no effect on relaxations whilst non-specific Kv blockade (1mM 4-
aminopyridine) enhanced vasorelaxations (n=4-6, Supplementary Figure 4).  
In the MA inhibition of EPAC with 100nmol/L ESI-09 produced a significant impairment of 
isoproterenol relaxations (Figure 3A, n=9). In contrast, PKA inhibition by 1µmol/L KT 5720 
(Figure 3C, n=10) or 1µmol/L PKI (Supplementary Figure 5), had no effect on isoproterenol 
relaxations. Linopirdine (10µmol/L) inhibited the isoproterenol relaxation in the presence of 
1µmol/L KT5720 (n=7), but not 100nmol/L ESI-09 (n=6) (Figure 3 B and D). To investigate 
whether there was any isoform specificity in the EPAC mediated relaxations we tested the 
relaxations to isoproterenol in the presence of 1µmol/L CE3F4 (EPAC1 inhibitor) and 
1µmol/L HJC0350 (EPAC2 inhibitor). Individually neither had any effect on isoproterenol 
relaxations (Figure 3E, n=6), but in combination they produced a significant impairment 
(Figurer 3F, n=5). 
Strikingly, EPAC inhibition with 300nmol/L ESI-09 in the RA had no effect on isoproterenol 
relaxations (Figure 4A, n=5) whilst PKA inhibition with 1µmol/L KT5720 (n=9) or 1µmol/L 
PKI (n=7) produced a significant inhibition (Figure 4B and 4C). Consistent with a role for 
PKA in this vessel, an inhibitor of PKA anchoring (Ht31, 10µmol/L) produced significant 
inhibition of the isoproterenol relaxation in RA (Figure 4D, n=7). 
Using the information obtained in the myograph experiments, we performed proximity 
ligation assays (PLA) on both MA and RA myocytes stimulated with 1μmol/L isoproterenol to 
detect the localisation of several signalling intermediaries with the Kv7.4 subunit. We 
investigated both AKAP (as a downstream modulator of PKA) and Rap proteins 
(downstream of EPAC). In MA there was an increase in Kv7.4-Rap1a (Figure 5A, N=3, 
n=16) and Kv7.4-Rap2 after isoproterenol stimulation (Figure 5B, N=3, n=15). High basal 
levels of Kv7.4-AKAP were detected, but surprisingly these decreased significantly in 
stimulated cells (Figure 5C, N=4, n=19). Conversely in RA, Kv7.4- AKAP levels increased 
after isoproterenol treatment (Figure 6C, N=3, n=15) but no increase in Kv7.4-Rap1a 
(Figure 6A, N=3, n=13) or Kv7.4-Rap2 was seen (Figure 6B, N=2, n=10). There was no 
change in Kv7.4-Rap1b levels in isoproterenol treated MA or RA myocytes (Supplementary 
Figure 6A and 6B). All antibody combinations were tested in untransfected HEK293 cells 
and produced low numbers of puncta (<5/cell) in these conditions (Supplementary Figure 
6C). 
Discussion 
Here we provide the first evidence that EPAC dependent relaxations involve Kv7 channels 
and that EPAC signalling contributes to an endogenous vasodilatory response in the rat 
mesenteric artery. To our knowledge this is the first account of an activation of an ion 
channel by the same endogenous vasodilator via different intracellular signalling pathways. 
Moreover, we show that the signalling intermediate linking β-adrenoceptors to Kv7 channel 
differs in RA compared to MA 
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Since the discovery of EPAC as a downstream mediator of cAMP signalling, its’ role in 
vascular biology has been under scrutiny. EPAC was first shown to be involved in vascular 
relaxations when a role in the downregulation of RhoA activity resulting in Ca2+ 
desensitisation was identified13. Subsequently, EPAC dependent relaxation of rat mesenteric 
arteries was shown to involve BKCa channel activation18. Whilst EPAC had previously been 
shown to negatively regulate vascular KATP channels31, this enhancement of BKCa was the 
first account of the positive modulation of a K+ channel by EPAC. Our data shows that Kv7 
channels underlie, in part, the EPAC dependent vasorelaxation in rat MA and RA. We 
therefore propose that Kv7 channels are significant players in mediating EPAC dependent 
vasorelaxations in the rat vasculature. 
Having established that EPAC stimulates Kv7 channels and produces vasorelaxations in a 
linopirdine sensitive manner, we investigated the role of EPAC signalling in a receptor 
mediated vasorelaxant pathway. Isoproterenol is a well characterised cAMP generator and 
vasorelaxant. In the mesenteric artery the potassium channel(s) underlying this has been 
debated for some time. Isoproterenol and cAMP dependent relaxations were initially 
believed to involve KATP channels32, however it has since been shown that although this 
results in membrane hyperpolarisation33-35 these channels do not contribute directly to 
vasorelaxation as glibenclamide has no effect on these relaxations 36-38, present study. The BKCa 
channel has also been implicated in the vasoactive properties of isoproterenol 37-40, present study 
and we report that like the EPAC dependent relaxation this is an effect which is additive to 
the role of Kv7 channels. Kv7 channels contribute to the EPAC dependent component, again 
an interesting parallel with BKCa channels which were reported to contribute to a PKA 
independent component 37 (prior to the discovery of EPAC). Discovering the mechanisms 
which dually regulate Kv7 and BKCa channels in the mesenteric artery will be an interesting 
area of future study. Notably, our study did not show a dependence upon the endothelium 
for the EPAC dependent relaxation as shown previously18, 19. Whilst we saw a wide range of 
relaxation responses to 5µmol/L 8-CPT-2Me-cAMP, this was not correlated to the 
responsiveness to 10µmol/L carbachol. A similar trend, or lack thereof, was seen with the 
responsiveness of the MA to 1µmol/L isoproterenol – this varied considerably between 
vessels, but no clear correlation was seen between this and the response to carbachol 
(Supplementary Figure 7). The role of the endothelium in isoproterenol dependent relaxation 
has been debated intensively for many years see refs 35, 41-43. From our data with both 
isoproterenol and 8-CPT-2Me-cAMP we conclude that our data does not indicate that these 
are purely endothelial dependent responses, but this does not rule out a role for the 
endothelium completely. Therefore the reason for the variability is unclear, but could 
represent the inherent differences present in each animal. 
We report that isoproterenol treated MA myocytes show an increase in PLA puncta between 
Kv7.4 and both Rap1a and Rap2 – small G proteins downstream of EPAC. Rap1 proteins 
have crucial effects within the vasculature15, with knockout of a singular isoform resulting in 
gross cardiovascular defects such as defective platelet function44, angiogenesis45, 46 and 
hypertension14, whilst Rap2 proteins are involved in arteriogenesis17. Both Rap1a and Rap 2 
are involved in membrane translocation of cellular components in the vasculature 16, 47, 48, 
and we propose that this may be a possible mechanism that is involved in the response of 
Kv7.4 channels to EPAC stimulation, although it is not yet clear if this is via direct or indirect 
effects on the channel, and aim to investigate this further.  
This work confirms previous findings from our lab that Kv7 channels mediate isoproterenol 
dependent relaxations in the renal artery1. Similar to the MA, we now report that this is in 
combination with BKCa channel activity, as inhibitors of either channel attenuated the 
relaxation. However, we did not see an additive effect of BKCa and Kv7 channel inhibition as 
we had in the MA. The reason for this is unclear, but we speculate that it is due to reduced 
permeability in RA which is a much tougher vessel than the MA. We further show that unlike 
the MA this relaxation is dependent upon PKA, and we see an increase in Kv7.4-AKAP 
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localisation in RA myocytes after isoproterenol stimulation. AKAP is known to form 
multifunctional signalling complexes and has been shown to be regulatory to both cardiac 
(Kv7.1)7 and neuronal (Kv7.2, 7.3 and 7.5)8, 9, 49 Kv7 channels. Here we demonstrate that 
this could also be an important regulatory mechanism of Kv7 channels in the vasculature, a 
finding which warrants further study. We investigated the interactions with Kv7.4 due to its’ 
crucial role in the regulation of the vasculature, as highlighted by the impact of KCNQ4 
knockdown 4, 27, and the stimulating effect of EPAC on Kv7.4 dependent currents. An 
overexpression system was used to remove artery specific ion channel structure and these 
experiments represent a proof of concept that side steps the vagaries of individual arteries. 
However one caveat to this is that it is known that Kv7.5 channels form heterotetramers with 
Kv7.4 in the vasculature4, 50, and Kv7.5 has been shown to be an endpoint for PKA 
dependent signalling in response to isoproterenol treatment in MA51. We confirm here 
previous reports that isoproterenol dependent relaxations in MA are primarily PKA-
independent37 suggesting that this modulation of Kv7.5 may play a role of other aspects of 
the vascular response to isoproterenol. One further complexity is the relationship of EPAC 
signalling with  G proteins, recently shown to enhance Kv7.4 channels and necessary for 
receptor-mediated stimulation in RA smooth muscle cells22. 
This study reveals a complex, regulation of Kv7 channels by cAMP dependent signals, which 
is artery specific. That isoproterenol mediated signalling couples to Kv7 channels via a 
PKA/AKAP axis in the RA, but an EPAC/Rap axis in the MA, is highly intriguing. Our data 
shows that EPAC stimulation is capable of producing Kv7 dependent relaxations in the RA, 
showing that it is not the case that this pathway is redundant here. One possible explanation 
is that EPAC is known to be under the control of distinct, compartmentalised molecular 
complexes which display specific cellular distribution. That EPAC dependent signals involve 
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 Kv7 channels contribute to EPAC dependent signals in both rat renal and mesenteric 
arteries 
 EPAC signalling is involved in isoproterenol mediated vasorelaxations of the rat 
mesenteric artery, but in the renal artery this is a predominantly PKA/AKAP 
dependent response 
 Isoproterenol stimulation results in increased localisation of Kv7.4 with Rap1a and 
Rap2 - EPAC effectors – in mesenteric arteries, but not in the renal artery. Here, we 









Figure 1 – EPAC dependent relaxations of MA and RA involve Kv7 channels 
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(A) Representative trace of a MA contracted with U46619 and stimulated with 5µmol/L 8-
pCPT-2Me-cAMP-AM in DMSO (control, black) and in the presence of 10µmol/L linopirdine 
(grey). Mean relaxant effect of 5µmol/L 8-pCPT-2Me-cAMP-AM in mesenteric (B) and renal 
arteries (C) in control or in the presence of 1µmol/L paxilline (BKCa inhibitor), 1µmol/L and 
10µmol/L linopirdine (Kv7 inhibitor), and in combination. Current voltage relationship of the 
linopirdine sensitive currents (10µmol/L) in control and after stimulation with 1µmol/L 8-
pCPT-2Me-cAMP-AM in myocytes from MA (D) and RA (E). (D) Current voltage relationship 
of HEK293 Kv7.4 currents in control (closed circles, n=7) (E) Activation kinetics of Kv7.4 
currents in control and after stimulation with 1µmol/L 8-pCPT-2Me-cAMP-AM. A one-way 
ANOVA was performed to analyse isometric tension recording data. For analysis of Kv7.4 
currents a Bonferroni post-hoc test was performed following a two-way ANOVA. p<0.05 is 
denoted (*), p<0.01 is denoted (**) and p<0.001 is denoted (***). Results were deemed non-










Figure 3 – Isoproterenol relaxations in MA are EPAC dependent 
Dose dependent relaxations of MA by isoproterenol (1nmol/L-300nmol/L) in the presence of (A) 100nM/L ESI-09 (EPAC inhibitor, 
n=9),representative trace can be seen in (i) with mean data in (ii), (B) 100nmol/L ESI-09 and 10µmol/L linopirdine (n=6), (C) 1µmol/L KT5720 
(PKA inhibitor, n=10), (D) 1µmol/L KT5720 and 10µmol/L linopirdine (n=7), (E) 1µmol/L CE3F4 (n=6) or 1µmol/L HJC0350 (n=6) alone and (F) 
1µmol/L CE3F4 and 1µmol/L HJC0350 in combination (n=5). A Bonferroni post-hoc test was performed following a two-way ANOVA. p<0.05 is 








Figure 5 – Isoproterenol stimulation in MA alters localisation of Kv7.4 with signalling 
molecules 
Mean data for the number of PLA puncta and representative images for (A) Kv7.4-Rap1a (B) 
Kv7.4-Rap2 and (C) Kv7.4-AKAP detected in MA myocytes in control and after stimulation 
with 1µmol/L isoproterenol. Results were analysed using a one-way ANOVA where p<0.05 is 





Figure 6 – Isoproterenol stimulation in RA myocytes alters localisation of Kv7.4 with 
signalling molecules 
 
The number of PLA puncta detected in RA myocytes before and after stimulation with (A) 
Kv7.4-Rap1a, (B) Kv7.4-Rap2 and (C) Kv7.4-AKAP with representative images. Results 
were analysed using a one-way ANOVA where p<0.001 is denoted (***). Results were 
deemed non-significant when p>0.05. 
